BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31273318)

  • 1. Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex.
    Wang Q; Song H; Cheng H; Qi J; Nam G; Tan S; Wang J; Fang M; Shi Y; Tian Z; Cao X; An Z; Yan J; Gao GF
    Cell Mol Immunol; 2020 Sep; 17(9):966-975. PubMed ID: 31273318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of the two membrane-proximal Ig-like domains (D3D4) of LILRB1/B2: alternative models for their involvement in peptide-HLA binding.
    Nam G; Shi Y; Ryu M; Wang Q; Song H; Liu J; Yan J; Qi J; Gao GF
    Protein Cell; 2013 Oct; 4(10):761-70. PubMed ID: 23955630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
    Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Functional Basis for LILRB Immune Checkpoint Receptor Recognition of HLA-G Isoforms.
    Kuroki K; Matsubara H; Kanda R; Miyashita N; Shiroishi M; Fukunaga Y; Kamishikiryo J; Fukunaga A; Fukuhara H; Hirose K; Hunt JS; Sugita Y; Kita S; Ose T; Maenaka K
    J Immunol; 2019 Dec; 203(12):3386-3394. PubMed ID: 31694909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.
    Ryu M; Chen Y; Qi J; Liu J; Fan Z; Nam G; Shi Y; Cheng H; Gao GF
    PLoS One; 2011 Apr; 6(4):e19245. PubMed ID: 21559424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors.
    HoWangYin KY; Loustau M; Wu J; Alegre E; Daouya M; Caumartin J; Sousa S; Horuzsko A; Carosella ED; LeMaoult J
    Cell Mol Life Sci; 2012 Dec; 69(23):4041-9. PubMed ID: 22802125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes.
    Chen Y; Gao F; Chu F; Peng H; Zong L; Liu Y; Tien P; Gao GF
    J Mol Biol; 2009 Feb; 386(3):841-53. PubMed ID: 19230061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j).
    Shiroishi M; Kuroki K; Tsumoto K; Yokota A; Sasaki T; Amano K; Shimojima T; Shirakihara Y; Rasubala L; van der Merwe PA; Kumagai I; Kohda D; Maenaka K
    J Mol Biol; 2006 Jan; 355(2):237-48. PubMed ID: 16305801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity of the LILRB1 and LILRB2 coding regions in an admixed Brazilian population sample.
    Oliveira MLG; Castelli EC; Veiga-Castelli LC; Pereira ALE; Marcorin L; Carratto TMT; Souza AS; Andrade HS; Simões AL; Donadi EA; Courtin D; Sabbagh A; Giuliatti S; Mendes-Junior CT
    HLA; 2022 Oct; 100(4):325-348. PubMed ID: 35754199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the immunoregulatory receptor LILRB1 as a crystallisation chaperone for human class I MHC complexes.
    Mohammed F; Stones DH; Willcox BE
    J Immunol Methods; 2019 Jan; 464():47-56. PubMed ID: 30365927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of malaria RIFIN binding by LILRB1-containing antibodies.
    Chen Y; Xu K; Piccoli L; Foglierini M; Tan J; Jin W; Gorman J; Tsybovsky Y; Zhang B; Traore B; Silacci-Fregni C; Daubenberger C; Crompton PD; Geiger R; Sallusto F; Kwong PD; Lanzavecchia A
    Nature; 2021 Apr; 592(7855):639-643. PubMed ID: 33790470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords.
    McIntire RH; Sifers T; Platt JS; Ganacias KG; Langat DK; Hunt JS
    Placenta; 2008 Jul; 29(7):631-8. PubMed ID: 18538388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages.
    Zeller T; Lutz S; Münnich IA; Windisch R; Hilger P; Herold T; Tahiri N; Banck JC; Weigert O; Moosmann A; von Bergwelt-Baildon M; Flamann C; Bruns H; Wichmann C; Baumann N; Valerius T; Schewe DM; Peipp M; Rösner T; Humpe A; Kellner C
    Front Immunol; 2022; 13():929339. PubMed ID: 36389667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.
    Zeller T; Münnich IA; Windisch R; Hilger P; Schewe DM; Humpe A; Kellner C
    Front Immunol; 2023; 14():1240275. PubMed ID: 37781391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis.
    Bylińska A; Wilczyńska K; Malejczyk J; Milewski Ł; Wagner M; Jasek M; Niepiekło-Miniewska W; Wiśniewski A; Płoski R; Barcz E; Roszkowski P; Kamiński P; Malinowski A; Wilczyński JR; Radwan P; Radwan M; Kuśnierczyk P; Nowak I
    Mol Genet Genomics; 2018 Jun; 293(3):601-613. PubMed ID: 29234882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble human leukocyte antigen-g5 activates extracellular signal-regulated protein kinase signaling and stimulates trophoblast invasion.
    Guo Y; Lee CL; So KH; Gao J; Yeung WS; Yao Y; Lee KF
    PLoS One; 2013; 8(10):e76023. PubMed ID: 24098421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Epistatic Interaction between
    Oliveira-Caramez ML; Veiga-Castelli L; Souza AS; Cardili RN; Courtin D; Flória-Santos M; Donadi E; Giuliatti S; Sabbagh A; Castelli EC; Mendes-Junior CT
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.
    Giles J; Shaw J; Piper C; Wong-Baeza I; McHugh K; Ridley A; Li D; Lenart I; Antoniou AN; DiGleria K; Kuroki K; Maenaka K; Bowness P; Kollnberger S
    J Immunol; 2012 Jun; 188(12):6184-93. PubMed ID: 22593621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Leukocyte Immunoglobulin-Like Receptors Focusing on the Therapeutic Implications of the Subfamily B2.
    Hu Y; Lu X; Qiu W; Liu H; Wang Q; Chen Y; Liu W; Feng F; Sun H
    Curr Drug Targets; 2022; 23(15):1430-1452. PubMed ID: 36017847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.